Issue link: https://beckershealthcare.uberflip.com/i/1383677
85 CIO / HEALTH IT Trust the science 1688 AIM 4K Platform Orthopedic • General • Colorectal • ENT • Gynecology • Urology Stryker's visualization technology has been widely studied and over 340 peer-reviewed articles state its clinical utility and benefi ts in a variety of surgical procedures. SPY ENV mode SPY Overlay mode White Light mode SPY Contrast mode* Available for open surgery and minimally invasive surgery SPY CSF mode* Copyright © 2021 Stryker. Stryker Corporation or its affi liates own, use, or have applied for the following trademarks or service marks: Stryker and SPY. All other trademarks are trademarks of their respective owners or holders. Upon intravenous administration of SPY AGENT™ GREEN (Indocyanine green for injection, USP), the AIM Light Source and SafeLight™ Cable is used with SPY AGENT GREEN to provide real-time endoscopic visible and near infrared fl uorescence imaging. The SPY-PHI System is indicated for fl uorescence imaging of blood fl ow and tissue perfusion before, during, and after: vascular, gastrointestinal, organ transplant, and plastic, microsurgical, and reconstructive surgical procedures. The AIM Light Source and SafeLight Cable enable surgeons to perform minimally invasive surgery using standard endoscope visual light as well as visual assessment of vessels, blood fl ow and related tissue perfusion, and at least one of the major extra- hepatic bile ducts (cystic duct, common bile duct and common hepatic duct), using near-infrared imaging. Fluorescence imaging of biliary ducts with the AIM Light Source and SafeLight Cable is intended for use with standard-of-care white light and, when indicated, intraoperative cholangiography. The devices are not intended for standalone use for biliary duct visualization. Upon interstitial administration of SPY AGENT GREEN (ICG drug product), the AIM Light Source and SafeLightTM Cable is used to perform intraoperative fl uorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes. *image acquired via SPY PHI Contact us to learn more at www.1688AIM4K.com Google says about 20% of staff will work from home under new remote plan By Kelly Gooch G oogle has adopted a hybrid work- place model that will allow 20 per- cent of employees to permanently work from home and another 20 percent to work in new office locations, e Wall Street Journal reported May 5. e tech giant said the plan is part of its goal for a more flexible workplace. "Our campuses have been at the heart of our Google community and the majority of our employees still want to be on campus some of the time," Sundar Pichai, CEO of Google par- ent company Alphabet, wrote in an email to employees. "Yet many of us would also enjoy the flexibility of working from home a couple days of week, spending time in another city for part of the year, or even moving there per- manently. Google's future workplace will have room for all of these possibilities." Mr. Pichai said Google will move to a hybrid workweek where most employees work ap- proximately three days in the office and two days "wherever they work best." e company will also allow employees to apply to move to another office. Additionally, employees may apply for permanent remote work. With the overall changes, Mr. Pichai said he expects 60 percent of employees will work at their current office a few days a week, another 20 percent of staff would work in new office locations, and 20 percent would work from home permanently. He said workers will also be able to temporar- ily work from anywhere for up to four weeks per year with manager approval. By mid-June, workers will receive more de- tails about these changes and the application process, he wrote. e workplace changes come aer Google announced last December an extension of its remote work period through Sept. 1. Google is based in Mountain View, Calif., and has 140,000 employees. n